Costs and Outcomes of Chronic Heart Disease Care in the VHA
VHA 中慢性心脏病护理的成本和结果
基本信息
- 批准号:9015267
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2018-09-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAddressAdministratorAdministratorAmerican Hospital AssociationAmerican Hospital AssociationCardiologyCardiologyCardiovascular DiseasesCardiovascular DiseasesCardiovascular systemCardiovascular systemCaringCaringCause of DeathCause of DeathCharacteristicsCharacteristicsChronicChronicClinicalClinicalCongestive Heart FailureCongestive Heart FailureCost ControlDataDataDatabasesDatabasesDecision Support SystemsDecision Support SystemsDevicesDevicesDiagnosisDiagnosisEconomic InflationEconomicsEconomicsEnrollmentEnrollmentEventEventFaceFaceFeesFeesFrequenciesFrequenciesGoalsGoalsGrowthGrowthHealthHealthHealth BenefitHealth Care CostsHealth Care CostsHealth systemHealth systemHealthcareHealthcareHeart DiseasesHeart DiseasesHospitalizationHospitalizationHospitalsHospitalsHousingImaging TechniquesImaging TechniquesInformation ResourcesInformation ResourcesInterviewInterviewKnowledgeKnowledgeLeadershipLeadershipLinear ModelsLinear ModelsMeasuresMeasuresMedicalMedicalMedical centerMedical centerMedicare claimMedicare claimMedicineMedicineMethodologyMethodologyMyocardial IschemiaMyocardial IschemiaNeighborhoodsNeighborhoodsOutcomeOutcomeOutcome StudyOutcome StudyPatient CarePatient CarePatientsPatientsPatternPatternPerformancePerformancePharmaceutical PreparationsPharmaceutical PreparationsPlant RootsPlant RootsPoliciesPoliciesProcessProcessProviderProviderQualitative ResearchQualitative ResearchQuality of CareQuality of CareReportingReportingResearchResearchResearch MethodologyResearch MethodologyResearch PersonnelResearch PersonnelResearch Project GrantsResearch Project GrantsResourcesResourcesRiskRiskSeriesSeriesSourceSourceStandardizationStatistical Data InterpretationStructureStructureSurveysSurveysSurvival RateSurvival RateTechnologyTechnologyTelephoneTelephoneUnited States Centers for Medicare and Medicaid ServicesUnited States Centers for Medicare and Medicaid ServicesVeteransVeteransbasebasecardiovascular imagingcardiovascular imagingcare costscare outcomescomparativecomparativecostcostcost outcomesdata warehousedesigndesigndissemination researchdissemination researcheconomic outcomeexperienceexperiencehealth administrationhealth administrationimplantable deviceimplantable deviceimprovedimprovedimproved outcomeimproved outcomemortalitymultidisciplinarynew technologyoperationoperationpatient populationpatient populationpressurepressurepreventpreventprogramsprogramsprovider networksresearch data disseminationtheoriestheories
项目摘要
DESCRIPTION (provided by applicant):
Cardiovascular disease is the leading cause of death among veterans enrolled in the Veterans Health
Administration (VHA), and it is also a major component of the VHA's operating costs. In recent years, VHA has undertaken numerous quality-of-care initiatives to improve health outcomes in patients with heart disease. Simultaneously, fiscal pressures on VA's clinical operations have increased, and the VHA's is increasingly compelled to optimize the value of its health care (i.e., improve outcomes while conserving limited resources). While VHA continuously collects and reports numerous process-of-care quality measures to assess clinical performance across VA medical centers (VAMCs), there is much less known about cardiovascular outcomes and costs of care at the VAMC level. This absence of information prevents VHA leadership from having a clear picture of the comparative performance of VAMCs in providing high-quality cardiovascular care that maximizes value. Our multi-disciplinary team of highly experienced investigators in cardiovascular outcomes and economics proposes to compare the outcomes and costs of care for two widely prevalent and high-cost cardiovascular conditions-ischemic heart disease (IHD) and chronic heart failure (CHF)-across the VA's 150 VAMCs from fiscal year 2010 to 2014. The specific aims of the research project are: (1) to identify the VAMCs that consistently produced excellent risk-adjusted health outcomes for veterans with IHD and CHF during this five-year period and quantify the costs of care associated with producing these outcomes; (2) to identify and quantify the structural aspects of CHF/IHD care at these VAMCs that are most conducive to optimal outcomes and economic efficiency, with a particular focus on the influence of the local frequency of several high-cost components of care, including: cardiovascular imaging, implantable device utilization, off-station major cardiovascular care, and non-elective hospitalizations; and (3) to explore in depth the key clinical, programmatic, and leadership, and factors that produced these outcomes via interviews with the leadership and clinical providers at that nation's top-performing and low-performing VAMCs. To address these research aims, we will combine data from the VA's National Patient Care Databases, the VA's Decision Support System National Data Extract databases, and the VA's Fee Basis Care Database-all housed at the VA's Corporate Data Warehouse. Additional data will be obtained from the American Hospital Association's Annual Hospital Survey and from the VA/Centers for Medicare and Medicaid Services data available from the VA Information Resource Center. Multivariable statistical analyses using hierarchical generalized linear models will be conducted to investigate hospital-level outcomes and costs of cardiovascular care while controlling for key differences across VAMCs in their CHF and IHD patient populations. We will follow this quantitative analysis with a qualitative assessment of information collected in a series of telephone-based interviews with administrative and clinical leadership as well as front-line clinicians at the top 5 VAMCs and
bottom 5 VAMCs in terms of cardiovascular care value. This "grounded theory" qualitative analysis will identify the key institutional, programmatic, and leadership factors that characteriz the nation's top-performing VA Medical Centers (VAMCs) in high-value IHD and CHF care, providing a critical blueprint to VA clinical and operations leaders seeking to improve cardiovascular care throughout the VA's health system. Our results subsequently will be communicated to key policy and clinical leaders in VA cardiology via the provider networks maintained by the VA's Chronic Heart Failure and Ischemic Heart Disease Quality Enhancement Research Initiatives (QUERIs), whose leaders will partner with the project's research team as co-investigators in the design and conduct of the study, as well as the dissemination of the research results.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER W. GROENEVELD其他文献
PETER W. GROENEVELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER W. GROENEVELD', 18)}}的其他基金
Impact of the MISSION Act on Quality and Outcomes of Interventional Cardiology and Cardiac Surgery among Veterans
《使命法案》对退伍军人介入心脏病学和心脏手术的质量和结果的影响
- 批准号:
10640085 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Costs and Outcomes of Chronic Heart Disease Care in the VHA
VHA 中慢性心脏病护理的成本和结果
- 批准号:
9888301 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Market and Organization Impact on Medical Technology Diffusion: Outcomes and Value
市场和组织对医疗技术传播的影响:结果和价值
- 批准号:
8800457 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Impact of New Technologies on Chronic Heart Failure Outcomes and Costs in the VHA
新技术对 VHA 慢性心力衰竭结果和成本的影响
- 批准号:
8292934 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Impact of New Technologies on Chronic Heart Failure Outcomes and Costs in the VHA
新技术对 VHA 慢性心力衰竭结果和成本的影响
- 批准号:
8084752 - 财政年份:2011
- 资助金额:
-- - 项目类别:
COMPARATIVE EFFECTIVENESS OF CARDIOVASCULAR DEVICES AND MEDICARE COST GROWTH
心血管设备的比较有效性和医疗保险成本增长
- 批准号:
7941932 - 财政年份:2009
- 资助金额:
-- - 项目类别:
COMPARATIVE EFFECTIVENESS OF CARDIOVASCULAR DEVICES AND MEDICARE COST GROWTH
心血管设备的比较有效性和医疗保险成本增长
- 批准号:
8120891 - 财政年份:2009
- 资助金额:
-- - 项目类别:
COMPARATIVE EFFECTIVENESS OF CARDIOVASCULAR DEVICES AND MEDICARE COST GROWTH
心血管设备的比较有效性和医疗保险成本增长
- 批准号:
7785491 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Racial Differences in BRCA1/2 Testing: Patients or Providers?
BRCA1/2 检测中的种族差异:患者还是提供者?
- 批准号:
8471069 - 财政年份:2009
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant














{{item.name}}会员




